AU5476601A - Method for diagnosing cancerous diseases and/or neuro-degenerative pathological conditions and products therefor - Google Patents

Method for diagnosing cancerous diseases and/or neuro-degenerative pathological conditions and products therefor

Info

Publication number
AU5476601A
AU5476601A AU54766/01A AU5476601A AU5476601A AU 5476601 A AU5476601 A AU 5476601A AU 54766/01 A AU54766/01 A AU 54766/01A AU 5476601 A AU5476601 A AU 5476601A AU 5476601 A AU5476601 A AU 5476601A
Authority
AU
Australia
Prior art keywords
neuro
pathological conditions
cancerous diseases
products therefor
diagnosing cancerous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU54766/01A
Inventor
Annette Hartmann
Oliver Nayler
Stefan Stamm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Original Assignee
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft zur Foerderung der Wissenschaften eV filed Critical Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Publication of AU5476601A publication Critical patent/AU5476601A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU54766/01A 2000-04-03 2001-04-02 Method for diagnosing cancerous diseases and/or neuro-degenerative pathological conditions and products therefor Abandoned AU5476601A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE2000116527 DE10016527A1 (en) 2000-04-03 2000-04-03 Methods for the diagnosis of cancer and / or neurodegenerative disease states and products therefor
DE10016527 2000-04-03
PCT/EP2001/003737 WO2001075441A1 (en) 2000-04-03 2001-04-02 Method for diagnosing cancerous diseases and/or neuro-degenerative pathological conditions and products therefor

Publications (1)

Publication Number Publication Date
AU5476601A true AU5476601A (en) 2001-10-15

Family

ID=7637432

Family Applications (1)

Application Number Title Priority Date Filing Date
AU54766/01A Abandoned AU5476601A (en) 2000-04-03 2001-04-02 Method for diagnosing cancerous diseases and/or neuro-degenerative pathological conditions and products therefor

Country Status (4)

Country Link
EP (1) EP1198711A1 (en)
AU (1) AU5476601A (en)
DE (1) DE10016527A1 (en)
WO (1) WO2001075441A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109310659B (en) * 2016-06-23 2021-04-16 国立研究开发法人科学技术振兴机构 Application of arginine or physiologically acceptable salt thereof in preparing pharmaceutical composition for treating or preventing PolyQ disease

Also Published As

Publication number Publication date
EP1198711A1 (en) 2002-04-24
DE10016527A1 (en) 2001-10-18
WO2001075441A1 (en) 2001-10-11

Similar Documents

Publication Publication Date Title
AU5788401A (en) Method of detecting cancerous lesions
AU2005897A (en) Methods for identifying human hereditary disease patterns
AU2002257235A1 (en) Method and system for recording carious lesions
AU2002243549A1 (en) Diagnostic and monitoring methods for cancer
AU2976599A (en) Breast biopsy system and method
AU2001243273A1 (en) System and method for diagnosing pathologic heart conditions
AU3367799A (en) Methodology for predicting and/or diagnosing disease
AU1465801A (en) Methods for cancer prognosis and diagnosis
AU2002220151A1 (en) Method and system for the detection of heart disease
AUPP446998A0 (en) Biopsy forceps
AU6518399A (en) Human ankyrin family protein
AU2002221906A1 (en) Method for diagnosing allergic diseases
AU2180897A (en) Method for the detection of prion diseases
AU2002364119A1 (en) System and method for diagnostic imaging
AU6105199A (en) Diagnostic method
AU8346498A (en) Method for diagnosing alzheimer disease
AU4150999A (en) Method and kit for early diagnosis of cancer
AU2002301109A1 (en) Method for the prediction of preeclampsia and other diseases
AU3671499A (en) Diagnostic markers of human female infertility
AU1163101A (en) Diagnostic methods
AU1914400A (en) Human hydrolase proteins
AU5476601A (en) Method for diagnosing cancerous diseases and/or neuro-degenerative pathological conditions and products therefor
AUPQ037799A0 (en) Methods for diagnosing and/or predicting the risk of gastric cancer
AU2194801A (en) Diagnostic method
AU6000600A (en) Diagnostic method

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase